The central nervous system complications of bone marrow transplantation in children

European Radiology

Volumn 18, Issue 10, 2008, Pages 2048-2059

  Yoshida, Shoko ^a   Hayakawa, Katsumi ^a   Yamamoto, Akira ^a   Kuroda, Hiroshi ^a   Imashuku, Shinsaku ^a  

^a KYOTO CITY HOSPITAL   (Japan)

Author keywords

Bone marrow transplantation; Central nervous system; Immunosuppression; Pediatrics

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOSPORIN A; METHOTREXATE; STEROID; T LYMPHOCYTE ANTIBODY; TACROLIMUS;

ARTICLE; ASPERGILLOSIS; BACTERIAL INFECTION; BONE MARROW SUPPRESSION; BONE MARROW TRANSPLANTATION; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; CENTRAL NERVOUS SYSTEM TUMOR; CENTRAL PONTINE MYELINOLYSIS; CEREBROVASCULAR DISEASE; CHILDHOOD CANCER; CHILDHOOD DISEASE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; DISSEMINATED NECROTIZING LEUKENCEPHALOPATHY; DISSEMINATED NECROTIZING LEUKOENCEPHALOPATHY; DRUG INDUCED DISEASE; DRUG MEGADOSE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOSUPPRESSIVE TREATMENT; LEUKOENCEPHALOPATHY; LYMPHOPROLIFERATIVE DISEASE; METABOLIC ENCEPHALOPATHY; MINIMAL RESIDUAL DISEASE; NEUROIMAGING; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDOME; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDRME; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; TUMOR IMMUNITY; VIRUS ENCEPHALITIS; WHOLE BODY RADIATION;

BONE MARROW TRANSPLANTATION; BRAIN DISEASES; CHILD; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 52049104204     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-008-1000-3     Document Type: Article

References (44)

1. Kliegman RM, Jensen HB, Behman RE, Stanson BF (2004) Nelson textbook of Pediatrics. 18th ed.Saunders Elsevier, Philadelphia, 924-34:1104-7
2. Kato K, Harada M (2005) Present status in hematopoietic stem cell transplantation: Peripheral blood stem cell transplantation. Nippon Naika Gakkai Zasshi 94:1281-1286
3. Harada M (2003) Hematopoietic stem cell transplantation therapy for leukemia. Nippon Naika Gakkai Zasshi 92:999-1006
4. Wiznitzer M, Packer RJ, August CS, Burkey ED (1984) Neurological complications of bone marrow transplantation in childhood. Ann Neurol 16:569-576
5. Sostak P, Padovan CS, Yousry TA, Ledderose G, Kolb HJ, Staube A (2003) Prospective evaluation of neurological complications after allogenic bone marrow transplantation. Neurology 60:842-848
6. Antonini G, Ceschin V, Morino S et al (1998) Early neurologic complications following allogenic bone marrow transplant for leukemia: A prospective study. Neurology 50:1441-1445
7. Graus F, Saiz A, Sierra J et al (1996) Neurologic complications of autologous and allogenic bone marrow transplantation in patients in leukemia: A comparative study. Neurology 46:1004-1009
8. Bleggi-Torres LF, Medeiros BC, Werner B et al (2000) Neuropathological findings after bone marrow transplantation: An autopsy study of 180 cases. Bone Marrow Transplant 25:301-307
9. Levine DS, Navarro OM, Chaudry G, Doyle JJ, Blaser S (2007) Imaging the complications of bone marrow transplantation in children. Radiographics 27:307-325 DOI 10.1148/rg.272065088
10. Uckan D, Cetin M, Yigitkanli I et al (2005) Life-threatening neurological complications after bone marrow transplantation in children. Bone Marrow Transplant 35:71-76 DOI 10.1038/sj.bmt.1704749
11. Dykewicz CA (2001) Summary of the Guidelines for preventing opportunistic infections among hematopoietic stem cell transplantat recipients. Clin Infect Dis 33:139-144 DOI 10.1086/321805
12. Sullivan KM, Dykewicz CA, Longworth DL et al (2001) Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology. Am Soc Hematol Educ Program 392-421
13. Coley SC, Jager HR, Szydlo RM et al (1999) CT and MRI manifestations of central nervous system infection following allogenic bone marrow transplantation. Clin Radiol 54:390-397 DOI 10.1053/crad.1999.0200
14. Guermazi A, Gluckman E, Tabti B, Myaux Y (2003) Invasive central nervous system aspergillosis in bone marrow transplantation recipients: An overview. Eur Radiol 13:377-388 DOI 10.1007/s00330-002-1480-5
15. Miaux Y, Williams M, Guermazi A et al (1995) MR of cerebral aspergillosis in patients who have had bone marrow transplantation. Am J Neuroradiol 16:555-562
16. Yamada K, Shrier DA, Rubio A et al (2002) Imaging findings in intracranial aspergillosis. Acad Radiol 9:163-171
17. Barkovich AJ (2005) Pediatric Neuroimaging. 4th. Lippincott Williams & Wilkins, Philadelphia, pp 843-844
18. Yoshikawa T (2003) Human herpesvirus-6 and -7 infections in transplantation. Pediatr Transplantation 7:11-17 DOI 10.1034/ j.1399-3046.2003.02094.x
19. Gorniak RJT, Young GS, Wiese DE, Marty FM, Schwarz RB (2006) MR imaging of human herpesvirus-6-associated encephalitis in 4 patients with anterograde amnesia after allogenic hematopoietic stem cell transplantation. Am J Neuroradiol 27:887-891
20. Urbach H, Soeder BM, Jeub M, Klockgether T, Meyer B, Bien CG (2006) Serial MR of limbic encephalitis. Neuroradiology 48:380-386 DOI 10.1007/ s00234-006-0069-0
21. Baskin HJ, Hedlund G (2007) Neuroimaging of herpes virus infections in children. Pediatr Radiol 37:949-963 DOI 10.1007/s00247-007-0506-1
22. Fukui MB, Williams RL, Mudigonda S (2001) CT and MR imaging features of pyogenic ventriculitis. AJNR 22:1510-1516
23. Pezzullo JA, Tung GA, Mudigonda S, Rogg JM, Jeffrey MR (2003) Diffusion-weighted MR imaging of pyogenic ventriculitis. AJR 180:71-75
24. Rana S, Albayram S, Lin DDM, Yousem DM (2002) Diffusion-weighted imaging and apparent diffusion coefficient maps in a case of intracerebral abscess with ventricular extension. AJNR 23:109-112
25. Han KT, Choi DS, Ryoo JW et al (2007) Diffusion-weighted MR imaging of pyogenic intraventricular empyema. Neuroradiology 49:813-818 DOI 10.1007/ s00234-007-0264-7
26. Osorio S, Camara R, Golbano N et al (2002) Progressive multifocal leukoencephalopathy after stem cell transplantation, unsuccessfully treated with cidofovir. Bone Marrow Transplant 30:963-966 DOI 10.1038/ sj.bmt.1703704
27. Unal S, Varan A, Yalcin B, Buyukpamukcm M, Gurgey A (2005) Evaluation of thrombotic children with malignancy. Ann Hematol 84:395-399 DOI 10.1007/ s00277-005-1004-x
28. Mitchell LG, Andrew M, Hanna K et al (2003) A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: Results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) study. Cancer 15:508-516 DOI 10.1002/cncr.11042
29. Ma M, Barnes G, Pulliam J, Jezek D, Baumann RJ, Berger JR (2002) CNS angitis in graft vs host disease. Neurology 59:1994-1997
30. Knaap MS, Valk J (2005) Magnetic resonance of myelination and myelin disorders. 3rd ed. Springer, Berlin, Heidelberg, 679-689, 808-817
31. Schwarz RB, Bravo SM, Klufas RA et al (1995) Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR 165:627-631
32. Mckinney AM, Short J, Truwit CL et al (2007) Posterior reversible encephalopathy syndrome: Incidence of atypical regions of involvement and imaging findings. AJR 189:904-912 DOI 10.2214/AJR.07.2024
33. Shimono T, Miki Y, Toyoda H et al (2003) MR imaging with quantitative diffusion mapping of tacrolimus-induced neurotoxicity in organ transplant patients. Eur Radiol 13:986-993 DOI 10.1007/s00330-002-1594-9
34. Trullemans F, Grignard F, Camp B, Schots R (2001) Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogenic bone marrow transplantation. Eur J Haematol 67:94-99 DOI 10.1034/j.1600-0609.2001.t01-1-00440.x
35. Pande AR, Ando K, Ishikura R et al (2006) Clinicoradiological factors influencing the reversibility of posterior reversible encephalopathy syndrome: A multicenter study. Radiat Med 24:659-668 DOI 10.1007/ s11604-006-0086-2
36. Reddick WE, Glass JO, Helton KJ et al (2005) Prevalence of leukoencephalopathy in children treated for acute lymphoblastic leukemia with high-dose methotrexate. AJNR 26:1263-1269
37. Reddick WE, Glass JO, Helton KJ et al (2005) A quantitative MR imaging assessment of leukoencephalopathy in children treated for acute lymphoblastic leukemia without irradiation. AJNR 26:2371-2377
38. Pande AR, Ando K, Ishikura R et al (2006) Disseminating necrotizing leukoencephalopathy following chemoradiation therapy for acute lymphoblastic leukemia. Radiat Med 24:515-519 DOI 10.1007/ s11604-006-0059-5
39. Fraser C, Charnas L, Orchard P (2005) Central pontine myelinolysis following bone marrow transplantation complicated by severe hepatic veno-occlusive disease. Bone Marrow Transplant 36:733-734 DOI 10.1038/ sj.bmt.1705115
40. Lones MA, Said JW, Shintaku IP, Kirov I, Neudorf S (2000) Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient. Bone Marrow Transplant 26:1021-1024
41. Pickhardt PJ, Siegel MJ, Hayashi RJ, Kelly M (2000) Posttransplantation lymphoproliferative disorder in children: Clinical, histopathologic, and imaging features. Radiology 217:16-25
42. Scarsbrook AF, Warakaulle DR, Dattani M, Traill Z (2005) Post-transplantation lymphoproliferative disorder: The spectrum of imaging appearances. Clin Radiol 60:47-55 DOI 10.1016/j.crad.2004.08.016
43. Gross TG, Steinbuch M, DeFor T et al (1999) B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: Risk factors, treatment and outcome. Bone Marrow Transplant 23:251-258
44. Kasow KA, Leung W, Horwitz EM, Woodand P, Handgretinger R, Hale GA (2007) EBV lymphoproliferative disease of host origin after haploidentical stem cell transplantation. Pediatr Blood Cancer 49:869-872 DOI 10.1002/pbc.20710